Skip to content

Differentiating pancreatogenic diabetes from other types of diabetes

To study the distinguishing features of pancreatogenic diabetes compared to young-onset Type 2 and autoimmune diabetes - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/109947
Enrollment
60
Registered
2026-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E138- Other specified diabetes mellituswith unspecified complications Health Condition 2: E108- Type 1 diabetes mellitus with unspecified complications Health Condition 3: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Nil: Nil

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with onset of diabetes mellitus 18 to 40 years 2) Patients of diabetes mellitus with BMI less than 25 kg/m2

Exclusion criteria

Exclusion criteria: 1)Patients with onset of diabetes mellitus more than 40 years 2)Patients of diabetes mellitus with BMI more than 25 kg/m2

Design outcomes

Primary

MeasureTime frame
clinical, demographic and biochemical profile of people with pancreatogenic diabetesTimepoint: 1 year

Secondary

MeasureTime frame
discriminatory features of pancreatogenic diabetes in comparison to young-onset Type 2 and autoimmune diabetes with low/normal BMITimepoint: 1 year

Countries

India

Contacts

Public ContactShakun Chaudhary

Dr RPGMC Kangra at Tanda

shakunchaudhary@yahoo.co.in09418233513

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026